Arthritis Foundation Forum
Home   
Welcome Guest ( Login | Register )
     



Long-term methotrexate appears safe in... Expand / Collapse
Author
Message
Posted Friday, July 03, 2009 3:47 PM


 

Group: Forum Members
Last Login: 2 days ago @ 8:50 AM
Posts: 1,737, Visits: 1,735
 

NEW YORK (Reuters Health) - In adults who suffer from rheumatoid arthritis (RA), long-term treatment with methotrexate (MTX) appears safe, according to pooled data from 88 studies of patients with RA treated with only MTX for at least 2 years.

"Overall, although many patients experience adverse events during MTX treatment, they are generally mild and withdrawals of MTX for toxicity are less common than for other disease-modifying anti-rheumatic drugs," Dr. C. Salliot of Hopital Cochin in Paris, France and Dr. D. van der Heijde of Leiden University Medical Center in The Netherlands conclude.

Over 12 years of treatment, the termination rate of MTX due to toxicity was less than for other commonly prescribed arthritis drugs such as sulfasalazine, gold, and D-penicillamine but higher than for hydrochloroquine, the researchers found.

Thirteen percent of patients taking MTX experienced potentially harmful spikes in liver enzymes, but only 3.7% discontinued MTX due to liver toxicity.

Data on risk of liver scarring or "fibrosis" with long-term MTX use were inconclusive. One study found a 2.7% rate of liver scarring in patients who took MTX for 4 years, but no evidence of liver damage in two other studies in which patients had repeated liver biopsies.

Long-term MTX did not appear to increase patients' risk for infections in general or for serious infections, including herpes zoster and infectious complications of joint replacement surgery.

Of two studies that estimated patients' risk of cardiovascular diseases during treatment, one concluded that MTX was not a risk factor and the other "even found a reduced risk" for treated patients compared to RA patients who had never received MTX, sulfasalazine, or hydrochloroquine. In fact, the researchers said, it's possible that MTX "could provide a survival benefit by reducing cardiovascular mortality."

There were not enough data to determine whether long-term MTX therapy increases patients' risk of lymphoma and other malignancies, according to the authors. They add, however, that "there is no strong evidence of increased risk."

SOURCE: Annals of the Rheumatic Diseases, June 2009.

Lynn

Rituxan....In Remission after 8 long years

“Over the last few centuries, a process developed for separating fact from fiction, and it is called science…’the crash testing of ideas.’”

The Microbial Metagenome, Debunking the Marshall protocol

 

http://whatstheharm.net/homeopathy.html

 


 

Post #4214189
Top
Posted Friday, July 03, 2009 5:32 PM


 

Group: Forum Members
Last Login: 2 days ago @ 1:40 AM
Posts: 93, Visits: 395
OK, I'm new, so this may be a silly question - but they mention long-term treatment with MTX and then state 2 years or longer.  Is 2 years on this drug considered "long-term"?

Donna

Post #4214194
Top
Posted Saturday, July 04, 2009 12:17 AM


 

Group: Forum Members
Last Login: Today @ 3:46 PM
Posts: 4,406, Visits: 3,526
I'm not sure if there is an official definition of "long term" but I think anything over a year is long term.  Medications for most conditions are used for a few weeks or months but RA is a chronic condition and usually requires lifelong treatment.  God bless.

Age 82, diagnosed RA 12/2001, married since 1952, 4 sons no daughters, 4 grandsons 1 granddaughter.  Doing well on Methotrexate and Remicade.
Post #4214220
Top
« Prev Topic | Next Topic »


All times are GMT -5:00, Time now is 5:28pm


Execution: 0.328. 43 queries. Compression Disabled.